Recombinant Expression in Pichia pastoris System of Three Potent Kv1.3 Channel Blockers: Vm24, Anuroctoxin, and Ts6

Author:

Borrego Jesús,Naseem Muhammad UmairORCID,Sehgal Al Nasar Ahmed,Panda Lipsa RaniORCID,Shakeel KashmalaORCID,Gaspar AttilaORCID,Nagy Cynthia,Varga ZoltanORCID,Panyi GyorgyORCID

Abstract

The Kv1.3 channel has become a therapeutic target for the treatment of various diseases. Several Kv1.3 channel blockers have been characterized from scorpion venom; however, extensive studies require amounts of toxin that cannot be readily obtained directly from venoms. The Pichia pastoris expression system provides a cost-effective approach to overcoming the limitations of chemical synthesis and E. coli recombinant expression. In this work, we developed an efficient system for the production of three potent Kv1.3 channel blockers from different scorpion venoms: Vm24, AnTx, and Ts6. Using the Pichia system, these toxins could be obtained in sufficient quantities (Vm24 1.6 mg/L, AnTx 46 mg/L, and Ts6 7.5 mg/L) to characterize their biological activity. A comparison was made between the activity of tagged and untagged recombinant peptides. Tagged Vm24 and untagged AnTx are nearly equivalent to native toxins in blocking Kv1.3 (Kd = 4.4 pM and Kd = 0.72 nM, respectively), whereas untagged Ts6 exhibits a 53-fold increase in Kd (Kd = 29.1 nM) as compared to the native peptide. The approach described here provides a method that can be optimized for toxin production to develop more selective and effective Kv1.3 blockers with therapeutic potential.

Funder

Hungarian National Research, Development, and Innovation Office

Tempus Public Foundation

Richter Gedeon Talentum Foundation

Publisher

MDPI AG

Subject

Plant Science,Ecology, Evolution, Behavior and Systematics,Microbiology (medical)

Reference51 articles.

1. The VGL-chanome: A protein superfamily specialized for electrical signaling and ionic homeostasis;Sci. STKE,2004

2. The voltage-gated potassium channel Kv1.3 is a promising multitherapeutic target against human pathologies;Expert Opin. Ther. Targets,2016

3. International Union of Pharmacology. LIII. Nomenclature and molecular relationships of voltage-gated potassium channels;Pharmacol. Rev.,2005

4. Voltage-Gated Potassium Channel Kv1.3 as a Target in Therapy of Cancer;Front. Oncol.,2019

5. Ion channels and anti-cancer immunity;Philos. Trans. R. Soc. Lond. B Biol. Sci.,2014

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3